Lam Research Corporation (NASDAQ:LRCX – Get Free Report) SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. This represents a 17.21% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
Lam Research Stock Up 0.4%
Lam Research stock opened at $138.31 on Wednesday. The firm has a market cap of $174.41 billion, a PE ratio of 33.25, a P/E/G ratio of 1.67 and a beta of 1.84. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.55 and a current ratio of 2.21. The firm’s 50 day moving average price is $116.42 and its two-hundred day moving average price is $95.48. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $153.70.
Lam Research (NASDAQ:LRCX – Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.12. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The firm had revenue of $5.17 billion for the quarter, compared to analyst estimates of $4.99 billion. During the same quarter in the prior year, the business earned $1.03 EPS. The company’s revenue for the quarter was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. On average, research analysts predict that Lam Research Corporation will post 3.71 EPS for the current fiscal year.
Lam Research Increases Dividend
Institutional Investors Weigh In On Lam Research
Institutional investors have recently modified their holdings of the business. Smallwood Wealth Investment Management LLC acquired a new stake in shares of Lam Research during the 1st quarter worth approximately $26,000. IMG Wealth Management Inc. bought a new position in Lam Research during the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new position in Lam Research during the 2nd quarter worth approximately $27,000. Strategic Wealth Investment Group LLC bought a new position in Lam Research during the 2nd quarter worth approximately $29,000. Finally, Delos Wealth Advisors LLC bought a new position in Lam Research during the 2nd quarter worth approximately $30,000. Institutional investors and hedge funds own 84.61% of the company’s stock.
Wall Street Analysts Forecast Growth
LRCX has been the topic of a number of research analyst reports. Cantor Fitzgerald raised their target price on shares of Lam Research from $155.00 to $170.00 and gave the company an “overweight” rating in a research note on Tuesday. B. Riley increased their price target on shares of Lam Research from $130.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, September 24th. Argus increased their price target on shares of Lam Research from $105.00 to $120.00 and gave the company a “buy” rating in a report on Friday, August 1st. Barclays set a $83.00 price target on shares of Lam Research and gave the company an “equal weight” rating in a report on Monday, July 28th. Finally, KeyCorp increased their price target on shares of Lam Research from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Tuesday, July 15th. Twenty-three analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. Based on data from MarketBeat, Lam Research has an average rating of “Moderate Buy” and a consensus target price of $123.80.
View Our Latest Research Report on Lam Research
Lam Research Company Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Articles
- Five stocks we like better than Lam Research
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- After Gold Blast Soars Past $4,000, BofA Eyes $5,000 in 2026
- How to Calculate Return on Investment (ROI)
- Buyback Boom: 3 Companies Betting Big on Themselves
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Analysts Flock to Upgrade DELL After Big AI-Server Guidance Boost
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.